Loading...
Cytek Biosciences, Inc.
CTKB•NASDAQ
Healthcare
Medical - Devices
$3.69
$0.36(10.81%)
Cytek Biosciences, Inc. (CTKB) Financial Performance & Income Statement Overview
Review Cytek Biosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.85%
↑ 3.85%
Operating Income Growth
26.30%
↑ 26.30%
Net Income Growth
50.44%
↑ 50.44%
Operating Cash Flow Growth
380.57%
↑ 380.57%
Operating Margin
-12.57%
↓ 12.57%
Gross Margin
54.94%
↑ 54.94%
Net Profit Margin
-5.71%
↓ 5.71%
ROE
-2.90%
↓ 2.90%
ROIC
-5.97%
↓ 5.97%
Cytek Biosciences, Inc. (CTKB) Income Statement & Financial Overview
Review Cytek Biosciences, Inc.'s (CTKB) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $57.48M | $51.50M | $46.62M | $44.86M |
| Cost of Revenue | $23.82M | $22.50M | $21.18M | $21.85M |
| Gross Profit | $33.65M | $29.005M | $25.44M | $23.01M |
| Gross Profit Ratio | $0.59 | $0.56 | $0.55 | $0.51 |
| R&D Expenses | $9.72M | $9.88M | $10.001M | $9.80M |
| SG&A Expenses | $20.94M | $23.37M | $23.96M | $23.95M |
| Operating Expenses | $33.27M | $33.25M | $33.96M | $33.75M |
| Total Costs & Expenses | $54.49M | $55.75M | $55.14M | $55.59M |
| Interest Income | $6.15M | $1.43M | $1.42M | $1.36M |
| Interest Expense | -$694000.00 | $119000.00 | $134000.00 | $441000.00 |
| Depreciation & Amortization | $2.74M | $2.81M | $2.48M | $2.46M |
| EBITDA | -$2.45M | $3.08M | -$4.57M | -$6.09M |
| EBITDA Ratio | -$0.04 | $0.06 | -$0.10 | -$0.14 |
| Operating Income | $2.99M | -$4.25M | -$8.53M | -$10.73M |
| Operating Income Ratio | $0.05 | -$0.08 | -$0.18 | -$0.24 |
| Other Income/Expenses (Net) | $7.34M | $4.41M | $1.34M | $1.74M |
| Income Before Tax | $10.32M | $157000.00 | -$7.19M | -$8.99M |
| Income Before Tax Ratio | $0.18 | $0.003 | -$0.15 | -$0.20 |
| Income Tax Expense | $680000.00 | -$784000.00 | $3.25M | -$2.82M |
| Net Income | $9.64M | $941000.00 | -$10.43M | -$6.17M |
| Net Income Ratio | $0.17 | $0.02 | -$0.22 | -$0.14 |
| EPS | $0.07 | $0.007 | -$0.08 | -$0.05 |
| Diluted EPS | $0.07 | $0.007 | -$0.08 | -$0.05 |
| Weighted Avg Shares Outstanding | $129.21M | $131.004M | $131.44M | $130.92M |
| Weighted Avg Shares Outstanding (Diluted) | $129.21M | $132.79M | $131.44M | $130.92M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan